Doctors still wary of Elan's Tysabri - survey
RTE.ie - Ireland
US doctors are proving more wary than many had expected about prescribing Elan's multiple sclerosis drug Tysabri, which was relaunched in July after being ...
See all stories on this topic

International Approvals: Sebivo and Tysabri
Medscape (subscription) - USA
... On October 5, Health Canada approved natalizumab intravenous infusion (Tysabri, made by Biogen Idec and Elan Corporation, plc) as monotherapy to delay the ...